These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 23334618)

  • 1. Single injection of triamcinolone versus three repeated injections of bevacizumab for treatment of diabetic macular edema.
    Taş M; Oner V; Alakuş MF; Türkcü FM; Işcan Y; Yüksel K
    Int Ophthalmol; 2013 Aug; 33(4):375-80. PubMed ID: 23334618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal bevacizumab combined with/without triamcinolone acetonide in single injection for treatment of diabetic macular edema.
    Wang YS; Li X; Wang HY; Zhang ZF; Li MH; Su XN
    Chin Med J (Engl); 2011 Feb; 124(3):352-8. PubMed ID: 21362332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal bevacizumab (Avastin) versus triamcinolone (Volon A) for treatment of diabetic macular edema: one-year results.
    Kriechbaum K; Prager S; Mylonas G; Scholda C; Rainer G; Funk M; Kundi M; Schmidt-Erfurth U;
    Eye (Lond); 2014 Jan; 28(1):9-15; quiz 16. PubMed ID: 24336297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phacoemulsification with intravitreal bevacizumab and triamcinolone acetonide injection in diabetic patients with clinically significant macular edema and cataract.
    Akinci A; Muftuoglu O; Altınsoy A; Ozkılıc E
    Retina; 2011 Apr; 31(4):755-8. PubMed ID: 21124251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bevacizumab versus triamcinolone for persistent diabetic macular edema: a randomized clinical trial.
    Rodrigues MW; Cardillo JA; Messias A; Siqueira RC; Scott IU; Jorge R
    Graefes Arch Clin Exp Ophthalmol; 2020 Mar; 258(3):479-490. PubMed ID: 31873786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the short-term effects of intravitreal triamcinolone acetonide and bevacizumab injection for diabetic macular edema.
    Song JH; Lee JJ; Lee SJ
    Korean J Ophthalmol; 2011 Jun; 25(3):156-60. PubMed ID: 21655039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema.
    Sheth S; Rush R; Natarajan S; Gillies M
    Clin Exp Ophthalmol; 2011; 39(7):673-81. PubMed ID: 22452685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing intravitreal triamcinolone acetonide and bevacizumab injections for the treatment of diabetic macular oedema: a randomized double-blind study.
    Isaac DL; Abud MB; Frantz KA; Rassi AR; Avila M
    Acta Ophthalmol; 2012 Feb; 90(1):56-60. PubMed ID: 20015098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between intravitreal bevacizumab and triamcinolone for macular edema secondary to branch retinal vein occlusion.
    Kim JY; Park SP
    Korean J Ophthalmol; 2009 Dec; 23(4):259-65. PubMed ID: 20046685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X; Li J; Hu X; Yu S; Pan J; Tang S
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of intravitreal bevacizumab alone or combined with triamcinolone versus triamcinolone in diabetic macular edema: a randomized clinical trial.
    Lim JW; Lee HK; Shin MC
    Ophthalmologica; 2012; 227(2):100-6. PubMed ID: 21997197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective comparisons of intravitreal injections of triamcinolone acetonide and bevacizumab for macular oedema due to branch retinal vein occlusion.
    Higashiyama T; Sawada O; Kakinoki M; Sawada T; Kawamura H; Ohji M
    Acta Ophthalmol; 2013 Jun; 91(4):318-24. PubMed ID: 22132711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of intravitreal triamcinolone acetonide versus intravitreal bevacizumab as the primary treatment of clinically significant macular edema.
    Liu Q; Hu Y; Yu H; Yuan L; Hu J; Atik A; Guan M; Li D; Li X; Tang S
    Retina; 2015 Feb; 35(2):272-9. PubMed ID: 25105313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of Retinal Sensitivity to Intravitreal Anti-angiogenic Bevacizumab and Triamcinolone Acetonide for Patients with Diabetic Macular Edema over One Year.
    Mylonas G; Schranz M; Scholda C; Karst S; Reiter G; Baumann L; Schmidt-Erfurth U; Kriechbaum K
    Curr Eye Res; 2020 Sep; 45(9):1107-1113. PubMed ID: 31961224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Posterior Subtenon Triamcinolone Acetonide Injection on Diabetic Macular Edema Refractory to Intravitreal Bevacizumab Injection.
    Kim MW; Moon H; Yang SJ; Joe SG
    Korean J Ophthalmol; 2016 Feb; 30(1):25-31. PubMed ID: 26865800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal bevacizumab alone or combined with 1 mg triamcinolone in diabetic macular edema: a randomized clinical trial.
    Riazi-Esfahani M; Riazi-Esfahani H; Ahmadraji A; Karkhaneh R; Mahmoudi A; Roohipoor R; Ghasemi F; Yaseri M
    Int Ophthalmol; 2018 Apr; 38(2):585-598. PubMed ID: 28349504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early change of central macular thickness after intravitreous triamcinolone or bevacizumab in diabetic macular edema or retinal vein occlusion.
    Sonoda Y; Arimura N; Shimura M; Sakamoto T
    Retina; 2011 Feb; 31(2):290-7. PubMed ID: 21102366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema secondary to branch retinal vein occlusion.
    Cheng KC; Wu WC; Chen KJ
    Eye (Lond); 2009 Nov; 23(11):2023-33. PubMed ID: 19798117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study).
    Paccola L; Costa RA; Folgosa MS; Barbosa JC; Scott IU; Jorge R
    Br J Ophthalmol; 2008 Jan; 92(1):76-80. PubMed ID: 17965109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema.
    Soheilian M; Ramezani A; Bijanzadeh B; Yaseri M; Ahmadieh H; Dehghan MH; Azarmina M; Moradian S; Tabatabaei H; Peyman GA
    Retina; 2007; 27(9):1187-95. PubMed ID: 18046223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.